Latest Oncology News

Botensilimab/Balstilimab Combo Shows Potential for MSS CRC

January 31, 2023

In an interview with Targeted Oncology, Benjamin Schlechter, MD, FACS, discussed the background of a phase 1a/1b trial in microsatellite stable colorectal cancer and how these findings will influence future research.

Taking on the Challenge to Develop New Therapies for Pediatric Solid Tumors

January 31, 2023

Both pediatric brain cancers and sarcomas have an extremely dismal outcome in the relapse setting, according to Catherine Bollard, MD. A new Cancer Grand Challenge aims to address the issue with the development of new therapies.

TOPAZ-1 Data Support New Frontline Option in Patients With BTC

January 30, 2023

During a Targeted Oncology case-based roundtable event, Nilofer S. Azad, MD, discussed the data supporting the previous standard of care and the new frontline regimen of gemcitabine, cisplatin, and durvalumab for patients with biliary tract cancers.